Loading...
XJPX
3386
Market cap50mUSD
Dec 05, Last price  
1,358.00JPY
1D
-2.86%
1Q
13.17%
Jan 2017
8.21%
IPO
-49.52%
Name

Cosmo Bio Co Ltd

Chart & Performance

D1W1MN
XJPX:3386 chart
P/E
30.13
P/S
0.79
EPS
45.07
Div Yield, %
3.68%
Shrs. gr., 5y
-0.38%
Rev. gr., 5y
5.75%
Revenues
10.04b
+7.46%
7,590,000,0008,092,000,0009,231,000,0009,553,000,0009,340,000,00010,037,000,000
Net income
262m
-40.72%
237,000,000674,000,000737,000,000517,000,000442,000,000262,000,000
CFO
241m
-67.26%
569,000,000803,000,000648,000,000284,000,000736,000,000241,000,000
Dividend
Dec 29, 202525 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cosmo Bio Company,Limited engages in the import, export, manufacture, marketing, and sale of life science research biotools. Its life science research tools include reagents, kits, instruments, software, and diagnostics products. The company offers research reagents, such as antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, bacteria, and others, as well as offers detection reagents, cell and tissue culture systems, gene analysis systems, and others. It also provides research instruments comprising electrophoresis apparatuses, cell culture labware, gene manipulation systems, data analysis software, and others; drug discovery and custom research services; and clinical diagnostics. In addition, the company develops and manufactures cell/cell culture products, including adipose tissue, bone, cartilage, tooth, pancreas, liver function, cardiovascular, immune, mesenchymal stem, and feeder cells, as well as tumor cell lines, coating reagents, macrophage-related products, etc.; and assay kit related products that comprise various measurement kits, staining kits, detection/purification kits, etc. Further, it offers biotechnology research equipment, which include constant-temperature transport containers, aluminum block mat heat insulation devices, dew condensation prevention glass plates, etc.; and consigned, custom peptide synthesis, and antibody production services. The company serves laboratories, research institutes, and life-science education and testing organizations. It sells its products through outlets in Japan, as well as a network of sales agents internationally. Cosmo Bio Company,Limited was founded in 1978 and is headquartered in Tokyo, Japan.
IPO date
Sep 27, 2005
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT